the disposition of, and the placing of liens on, the stock of designated subsidiaries, limitations on mergers, amalgamations and consolidations, limitations on third-party investor redemptions, a leverage covenant and a covenant to maintain certain ratings. The net proceeds from this offering were used to repay, in full, $100.0 million outstanding under the loan agreement, dated as of March 30, 2011, between DaVinciRe and RenaissanceRe, and the remainder of the net proceeds were used for general corporate purposes. Scheduled Debt Maturity The following table sets forth the scheduled maturity of the Company’s aggregate amount of its debt obligation reflected on its consolidated balance sheet at December 31, 2021: 2022 $ 30,000 2023 — 2024 — 2025 450,000 2026 — After 2026 700,000 Unamortized fair value adjustments — Unamortized discount and debt issuance expenses (11,647) $ 1,168,353 Credit Facilities The outstanding amounts issued or drawn under each of the Company’s significant credit facilities is set forth below: At December 31, 2021 Issued or Drawn Revolving Credit Facility (1) $ — Medici Revolving Credit Facility (2) 30,000 Bilateral Letter of Credit Facilities Secured 410,440 Unsecured 369,324 Funds at Lloyd’s Letter of Credit Facility 275,000 $ 1,084,764 (1) At December 31, 2021 , no amounts were issued or drawn under this facility. (2) RenaissanceRe owns a noncontrolling economic interest in Medici. Because RenaissanceRe controls all of Medici’s outstanding voting rights, the financial statements of Medici are included in RenaissanceRe’s consolidated financial statements. The drawn amount of the Medici revolving credit facility is included on the Company’s consolidated balance sheets under debt. RenaissanceRe Revolving Credit Facility RenaissanceRe, Renaissance Reinsurance, RenaissanceRe Specialty U.S., Renaissance Reinsurance U.S. and RREAG are parties to a second amended and restated credit agreement dated November 9, 2018 (as amended, the “Revolving Credit Agreement”) with various banks, financial institutions and Wells Fargo Bank, National Association (“Wells Fargo”) as administrative agent, which amended and restated a previous credit agreement. The Revolving Credit Agreement provides for a revolving commitment to RenaissanceRe of $500.0 million, with a right, subject to satisfying certain conditions, to increase the size of the facility to $700.0 million. Amounts borrowed under the Revolving Credit Agreement bear interest at a rate selected by RenaissanceRe equal to the Base Rate or LIBOR (each as defined in the Revolving Credit Agreement) plus a margin. In addition to revolving loans, the Revolving Credit Agreement provides that the entire facility will also be available for the issuance of standby letters of credit, subject to the terms and conditions set forth therein, and swingline loans, which are capped at $50.0 million for each of the swingline lenders. At December 31, 2021, RenaissanceRe had $Nil o utstanding under the Revolving Credit Agreement. F-57